• Explore /
  • Poster
  • / Prognostic impact of high stromal tumor-infiltrating lymphocytes (sTIL) in the absence of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in early stage triple negative breast cancer (TNBC).

Prognostic impact of high stromal tumor-infiltrating lymphocytes (sTIL) in the absence of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in early stage triple negative breast cancer (TNBC).

Abstract Poster

Authors

Nour Abuhadra

Nour Abuhadra

MD Anderson Hematology/Oncology Fellowship, Houston, TX

Nour Abuhadra , Ryan Sun , Jennifer Keating Litton , Gaiane M Rauch , Alastair Mark Thompson , Bora Lim , Beatriz E Adrada , Elizabeth A. Mittendorf , Jason B White , Elizabeth Ravenberg , Senthil Damodaran , Rosalind P Candelaria , Banu Arun , Naoto T. Ueno , Lumarie Santiago , Rashmi Krishna Murthy , Nuhad K. Ibrahim , William Fraser Symmans , Stacy L. Moulder , Lei Huo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 38: 2020 (suppl; abstr 583)

DOI

10.1200/JCO.2020.38.15_suppl.583

Abstract #

583

Poster Bd #

75

Abstract Disclosures

Similar Posters

First Author: Nour Abuhadra

First Author: Bora Lim

First Author: Reva K Basho

First Author: Stacy L. Moulder